.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Dow
Healthtrust
UBS
Cerilliant
Cantor Fitzgerald
Queensland Health
Medtronic
Deloitte

Generated: February 19, 2018

DrugPatentWatch Database Preview

Patents Expiring in May 2031

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck Sharp DohmeZEPATIERelbasvir; grazoprevirTABLET;ORAL208261-001Jan 28, 2016RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF PATIENTS INFECTED WITH HEPATITIS C VIRUS
Rempex PharmsMINOCINminocycline hydrochlorideINJECTABLE;INJECTION050444-001Approved Prior to Jan 1, 1982RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATING BACTERIAL INFECTIONS
Rempex PharmsMINOCINminocycline hydrochlorideINJECTABLE;INJECTION050444-001Approved Prior to Jan 1, 1982RXYesYes➤ Sign Up➤ Sign UpMETHOD OF TREATING BACTERIAL INFECTIONS
Teva Branded PharmPROAIR HFAalbuterol sulfateAEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes➤ Sign Up➤ Sign UpY
Sanofi Us ServicesTOUJEO SOLOSTARinsulin glargine recombinantSOLUTION;SUBCUTANEOUS206538-001Feb 25, 2015RXYesYes➤ Sign Up➤ Sign UpYIMPROVEMENT IN GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-003Jan 27, 2017RXYesYes➤ Sign Up➤ Sign UpY
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-002Jan 27, 2017RXYesNo➤ Sign Up➤ Sign UpY
Teva PharmARMONAIR RESPICLICKfluticasone propionatePOWDER;INHALATION208798-001Jan 27, 2017RXYesNo➤ Sign Up➤ Sign UpY
Teva PharmAIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoatePOWDER;INHALATION208799-003Jan 27, 2017RXYesYes➤ Sign Up➤ Sign UpY
Teva PharmAIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoatePOWDER;INHALATION208799-002Jan 27, 2017RXYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Dow
Julphar
Harvard Business School
Baxter
US Department of Justice
McKinsey
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot